Department of Psychiatry and Behavioral Medicine
USF Health

Francisco Fernandez, M.D.
Professor
Chairperson, Department of Psychiatry and Behavioral Medicine
Director, Institute for Research In Psychiatry
Interim Director, Silver Child Development Center

Contact Information

3515 E. Fletcher Avenue, USF Department of Psychiatry
Tampa, FL 33613
ffernand@health.usf.edu

Education

- Tufts University, M.D. 1979
- Harvard Medical School Massachusetts General Hospital General Psychiatry Residency 1983
- Harvard Medical School Massachusetts General Hospital Psychosomatic Medicine Fellowship 1984

Interests

1. Psychosomatic Medicine
2. Clinical Neurosciences
3. Neuro-AIDS

Patient Care

3515 E. Fletcher Avenue, Tampa, FL 33613
Call for Appointment

Publications
  1. Giunta B, Ehrhart J, Townsend K, Sun N, Vendrame M, Shytle D, Tan J, and Fernandez F: Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Research Bulletin, 64: 165-170, 2004
  2. Townsend KP, Shytle D, Bai Y, San N, Zeng J, Freeman M, Mori Takashi, Fernandez F, Morgan D, Sanberg P, and Tan J: Lovastatin modulation of microglial activation via suppression of CD40, J Neuroscience Research, 78: 167-176, 2004
  3. Goforth HW, Lupash DP, Brown ME, Tan J, Fernandez F: Role of Alcohol and Substance Abuse in the Immunomodulation of Human Immunodeficiency Virus Disease: A Review, Addictive Disorders and Their Treatment, 3:174-182, 2004
  4. Fernandez F: Ten Myths About HIV Infection and AIDS. Focus, III (No. 2): 184-193, 2005
  5. McBride A, Fernandez F: Cognitive Disorders. In, Fernandez F and Ruiz P (Eds.), Psychiatric Aspects of HIV/AIDS, Lippincott, Williams and Wilkins, Baltimore; Chapter 12, pp. 111-118, 2006
  6. Santana CA, Fernandez F: Sleep Disorders. In, Fernandez F and Ruiz P (Eds.), Psychiatric Aspects of HIV/AIDS, Lippincott, Williams, and Wilkins, Baltimore; Chapter 15, pp. 137-146, 2006
  7. Ruiz P, Fernandez F: Hispanics and AIDS. In, Fernandez F and Ruiz P (Eds.), Psychiatric Aspects of HIV/AIDS, Lippincott, Williams, and Wilkins, Baltimore; Chapter 20, pp. 215-225, 2006
  8. Giunta B, Obregon D, Hou H, Zeng J, Nikolic V, Ehrhart J, Shytle D, Fernandez F and Tan J. EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-g: role of JAK/STAT1 signaling and implications for HIV-associated dementia (2006). Brain Research 1123: 216-225.
  9. Fernandez F, Tan J: Neuropsychiatric Aspects of Human Immunodeficiency Virus Infection of the Central Nervous System. In, Yudofsky S.C. & Hales R. (Eds) The American Psychiatric Textbook of Neuro­psychiatry and Clinical Neurosciences, Washington, D.C.: American Psychiatric Press, Inc., Chapter 20, pp.765-798, 2007.